Epidemiology is the study of the distribution and determinants of health-related states or events in specified populations, and the application of this study to the control of health problems [1]. Epidemiological measures of interest for anaphylaxis include the incidence, incidence rate, lifetime prevalence of its occurrence and case fatality rate (Box 1). Other aspects of interest concern features of persons who experience it, temporal relationships, and the factors that lead to its development and recurrence. Anaphylaxis is a potentially life-threatening hypersensitivity reaction to a substance or set of factors to which the affected person is sensitive and people who experience an anaphylactic reaction remain at risk of further reactions. Accordingly, a description of its epidemiology is important to inform the development and evaluation of strategies to reduce its frequency of occurrence.
Anaphylaxis affects children and adults alike, but estimates of its incidence and lifetime prevalence vary across populations, with time in the same population, and with the data sources used to estimate them. One important reason for this imprecision relates to the great variability in clinical symptoms experienced [2]. An anaphylactic reaction can present with cutaneous, respiratory, cardiovascular or gastrointestinal symptoms that can be misinterpreted for other disorders [3]. The variety of physiological responses experienced by patients and the failure to identify specific biomarkers present during all attacks contributes to the uncertainty of diagnosis [4]. Accordingly, agreement on a case definition has proved elusive and this has contributed to difficulties of conducting research into its epidemiology [5, 6].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Last JM (2001) A dictionary of epidemiology, 4th edn. Oxford University Press, New York.
Ewan PA (1998) ABC of allergies. Anaphylaxis. BMJ 316:1442–1445.
Kumar A, Teuber SS, Gershwin ME (2005) Why do people die of anaphylaxis? A clinical review. Clin Develop Immunol 12:281–287.
Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF, Bock A, Branum A, Brown SGA, Camargo CA, Cydulka R, Galli SJ, Gidudu J, Gruchalla RS, Harlor AD, Hepner DL, Lewis LM, Lieberman PL, Metcalfe DD, O'Connor R, Muraro A, Rudman A, Schmitt C, Scherrer D, Simons ER, Thomas S, Wood JP, Decker WW (2006) Second symposium on the definition and management of anaphylaxis: Summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 117:391–397.
Neugut AI, Ghatak AT, Miller RL (2001) Anaphylaxis in the United States. An investigation into its epidemiology. Arch Intern Med 161:15–21.
Lieberman P, Camargo CA, Bohlke K, Jick H, Miller RL, Sheikh A, Simons FER (2006) Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy, Asthma Immunol 97:596–602.
American Academy of Pediatrics, Committee on School Health (1990) Guidelines for urgent care in school. Pediatrics 86:999–1000
International Collaborative Study of Severe Anaphylaxis (1998) An epidemiologic study of severe anaphylactic and anaphylactoid reactions among hospital patients: methods and overall risks. Epidemiology 9:141–146.
Australasian Society of Clinical Immunology and Allergy Inc. (ASCIA) (2004) Guidelines for EpiPen prescription. ASCIA Anaphylaxis Working Party. http://www.allergy.org.au/anaphy-laxis/epipen_guidelines.htm. Accessed 21st June 2007.
Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; and Joint Council of Allergy, Asthma, and Immunology (2005) The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 115(3 suppl):S483–S523.
Pumphrey RSH (2000) Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exper Allergy 30:1144–1150.
Peng MM, Jick H (2004) A population-based study of the incidence, cause and severity of anaphylaxis in the United Kingdom. Arch Intern Med 164:317–19.
Mullins RJ (2003) Anaphylaxis: risk factors for recurrence. Clin Exp Allergy 33:1033–1040.
Klein JS, Yocum MW (1995) Underreporting of anaphylaxis in a community emergency room. J Allergy Clin Immunol 95:637–638.
Bohlke K, Davis RL, DeStefano F, Marcy SM, Braun MM, Thompson RS (2004) Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy Clin Immunol 113:536–542.
Sørensen HT, Nielsen B, Nielson-Østergaard J (1989) Anaphylactic shock occurring outside hospitals. Allergy 44:288–290.
Pumphrey RSH, Davis S (1999) Under-reporting of antibiotic anaphylaxis may put patients at risk. Lancet 353:1157–1158.
Lieberman PL (2003) Anaphylaxis and anaphylactoid reactions. In: Adkinson NF Jr, Busse WW, Yunginger JW, et al (eds). Middleton's allergy principles and practice, 6th edn. Elsevier, St Louis, MO.
Boros CA, Kay D, Gold MS (2000) Parent reported allergy and anaphylaxis in 4173 South Australian children. J Paediatr Child Health 36:36–40.
Rankin KE, Sheikh A (2006) Serious shortcomings in the management of children with ana-phylaxis in Scottish schools. PLoS Med 3(8):e326. doi: 10.1371/journal.pmed.0030326
Yocum MW, Butterfield JH, Klein JS, Volcheck GW, Schroeder DR, Silverstein MD (1999) Epidemiology of anaphylaxis in Olmstead County, a population-based study. J Allergy Clin Immunol 104:452–456.
Gupta R, Sheikh A, Strachan D, Anderson HR (2004) Burden of allergic disease in the UK: secondary analyses of national databases. Clin Exp Allergy 34:520–26.
Helbling A, Hurni T, Mueller UR, Pichler WJ (2004) Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940,000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 34:285–290.
Sheikh A, Hippisley-Cox J, Newton J, Fenty J (2008). Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. J Roy Soc Med 101: 139–143.
Mulla ZD, Simon MR (2007) Hospitalizations for anaphylaxis in Florida: epidemiologic analysis of a population-based dataset. Int Arch Allergy Immunol 144:128–136.
Amornmarn L, Bernard L, Kumar N, et al (1992) Anaphylaxis admissions to a university hospital [abstract]. J Allergy Clin Immunol 89(suppl):349.
Stewart AG, Ewan PW (1996) The incidence, aetiology and management of anaphylaxis presenting to an accident and emergency department. Q J Med 89:859–864
Sheikh A, Alves B (2001) Age, sex, geographical and socioeconomic variations in admissions for anaphylaxis: analysis of four years of English hospital data. Clin Exp Allergy 31: 1571–76.
Pastorello EA, Rivolta F, Bianchi M, Mauro M, Pravettoni V (2001) Incidence of anaphylaxis in the emergency department of a general hospital in Milan. J Chromatogr B Biomed Sci Appl 756:11–17.
Brown AF, McKinnon D, Chu K (2001) Emergency department anaphylaxis: a review of 142 patients in a single year. J Allergy Clin Immunol 108:861–866
Smit De V, Cameron PA, Rainer TH (2005) Anaphylaxis presentations to an emergency department in Hong Kong: incidence and predictors of biphasic reactions. J Emer Med 28:381–388.
Braganza SC, Acworth JP, McKinnon DRL, Peake JE, Brown AFT (2006) Paediatric emergency department anaphylaxis: different patterns from adults. Arch Dis Child 91:159–163.
Poachanukoon O, Paopairochanakorn C (2006) Incidence of anaphylaxis in the emergency department: a 1-year study in a university hospital. Asian Pacific J Allergy Immunol 24:111–116.
Gupta R, Sheikh A, Strachan D, Anderson HR (2007) Time trends in allergic disorders in the UK. Thorax 62:91–96.
Simons FER, Peterson S, Black CD (2002) Epinephrine dispensing patterns for an out-of-hospital population; a novel approach to studying the epidemiology of anaphylaxis. J Allergy Clin Immunol 110:647–651
Sicherer SH, Simons ERS (2005) Quandries in prescribing an emergency action plan and self-injectable epinephrine for first-aid management of anaphylaxis in the community. J Allergy Clin Immunol 115:578–583.
Simons FER, Peterson S, Black CD (2001) Epinephrine dispensing for the out-of-hospital treatment of anaphylaxis in infants and children: a population-based study. Ann Allergy Asthma Immunol 86:622–626.
Bock SA, Muñoz-Furlong A, Sampson HA (2001) Fatalities due to anaphylactic reactions to food. J Allergy Clin Immunol 107:191–193.
Bock SA, Muñoz-Furlong A, Sampson HA (2007) Further fatalities caused by anaphylactic reactions to food, 2001–2006. J Allergy Clin Immunol 118:1016–1018.
Moneret-Vautrin DA, Morisset M, Flabbee J, Beaudouin E, Kanny G (2005) Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 60:443–451.
Population UK. http://www.statistics.gov.uk/CCI/nugget.asp?ID = 6. Accessed 6 Jun 2007.
National Patient Safety Agency (2007) Safety in doses: improving the use of medicines in the NHS. London.
Pumphrey RSH (2004) Fatal anaphylaxis in the UK, 1992–2001. 2004 anaphylaxis. Wiley (Novartis Foundation Symposium 257), Chichester, pp 116–132
Pumphrey R (2004) Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol 4:285–290
Pumphrey RSH, Gowland MH (2007) Further fatal allergic reactions to food in the United Kingdom, 1999–2006. J Allergy Clin Immunol 119:1018–1019.
Bernstein DI, Wanner M, Borish L, Liss GM, and the Immunotherapy committee of the American Academy of Allergy, Asthma and Immunology (2004) Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990–2001. J Allergy Clin Immunol 113:1129–1136.
Gupta R, Sheikh A, Strachan D, Anderson HR (2003) Increasing hospital admission for systematic allergic disorders in England: analysis of national admission data. BMJ 327:1142–1143
Alves B, Sheikh A (2001) Age-specific aetiology of anaphylaxis: a study of routine hospital admission data in England. Arch Dis Child 85:349.
Black CD, Peterson S, Simons FER (2001) Epinephrine for outpatient treatment of anaphylaxis: a population-based study. J Allergy Clin Immunol 107:S59
Pumphrey RSH, Stanworth SJ (1996) The clinical spectrum of anaphylaxis in north-west England. Clin Exp Allergy 26:1364–1370.
Slater JE (1993) Latex allergy. Ann Allergy 70:1–2.
Kemp SF, Lockey RF, Wolf BL, Lieberman P (1996) Anaphylaxis: a review of 266 cases. Arch Int Med 155:1749–1754
Quiralte J, Sanchez-Garcia F, Torres MJ, Blanco C, Castillo R, Ortega N, de Castro FR, Perez-Aciego P, Carillo T (1999) Association of HLA-DR11 with the anaphylactoid reaction caused by nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 103:685–689
Brown RH, Hamilton RG, Mintz M, Jedlicka AE, Scott AL, Kleeberger SR (2005) Genetic predisposition to latex allergy: role of interleukin 13 and interleukin 18. Anesthesiology 102:496–502.
Ewan PW, Clark AT. Long-term prospective observational study of the outcome of a management plan in patients with peanut and nut allergy referred to a regional allergy centre. Lancet 2001; 357:111–115.
Cianferoni A, Novembre E, Pucci N, Lombardi E, Bernardini R, Vierucci A (2004) Anaphylaxis: a 7-year follow-up survey of 46 children. Ann Allergy Asthma Immunol 92:464–468.
Yocum MW, Khan DA (1994) Assessment of patients who have experienced anaphylaxis: a 3-year survey. Mayo Clin Proc 69:16–23.
Sheikh A, Alves B (2000) Hospital admission for acute anaphylaxis: time trend study. BMJ 320:1441–1444.
Brown SGA (2004) Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 114:371–376.
Sicherer SH, Munoz-Furlong A, Burks AW, Sampson HA (1999) Prevalence of peanut and tree nut allergy in the US determined by a random digit dial telephone survey. J Allergy Clin Immunol 103:559–562.
Altman DR, Chiaramonte LT (1996) Public perception of food allergy. J Allergy Clin Immunol 97:1247–1251.
Pereira B, Venter C, Grundy J, Clayton CB, Arshad SH (2005) Prevalence of sensitisation to food allergens, reported adverse reaction to foods, food avoidance, and food hypersensitivity among teenagers. J Allergy Clin Immunol 116:884–892
Venter C, Pereira B, Grundy J, Clayton CB, Roberts G, Higgins B, Dean T (2006) Incidence of parentally reported and clinically diagnosed food hypersensitivity in the first year of life. J Allergy Clin Immunol 117:1118–1124.
SNOMED International, a division of the College of American Pathologists. www.snomed. org. Accessed 14 Jun 2007.
Choo K, Sheikh A (2007) Action plans for the long-term management of anaphylaxis:systematic review of effectiveness. Clin Exp Allergy 37:1090–1094
Fernando B, Savelyich BSP, Avery AJ, Sheikh A, Bainbridge M, Horsfield P, Teasdale S (2004) Prescribing safety features of general practice computer systems: evaluation using simulated test cases. BMJ 328:1171–1172.
Akeson N, Worth A, Sheikh A (2007) The psychosocial impact of anaphylaxis on young people and their parents. Clin Exp Allergy 37:1213–1220.
Anandan C, Simpson CR, Fischbacher C, Sheikh A (2006) Exploiting the potential of routine data to better understand the disease burden posed by allergic disorders. Clin Exp Allergy 36:866–871.
Clark S, Camargo CA (2007) Epidemiology of anaphylaxis. Immunol Allergy Clin N Am 27:145–163
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer
About this chapter
Cite this chapter
Chinn, D.J., Sheikh, A. (2009). Epidemiology of Anaphylaxis. In: Pawankar, R., Holgate, S.T., Rosenwasser, L.J. (eds) Allergy Frontiers: Epigenetics, Allergens and Risk Factors. Allergy Frontiers, vol 1. Springer, Tokyo. https://doi.org/10.1007/978-4-431-72802-3_8
Download citation
DOI: https://doi.org/10.1007/978-4-431-72802-3_8
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-72801-6
Online ISBN: 978-4-431-72802-3
eBook Packages: MedicineMedicine (R0)